At­las part­ner Sa­ha takes the helm at Delinia, look­ing to dis­rupt au­toim­mune R&D

As a ven­ture part­ner at At­las, Saurabh Sa­ha gets to look over a whole range of pre­clin­i­cal pro­grams that come its way, in­clud­ing pro­posed drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.